Beijing Leadman Biochemistry Co Ltd (300289) - Total Assets

Latest as of March 2026: CN¥1.76 Billion CNY ≈ $258.19 Million USD

Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) holds total assets worth CN¥1.76 Billion CNY (≈ $258.19 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Beijing Leadman Biochemistry Co Ltd (300289) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Beijing Leadman Biochemistry Co Ltd - Total Assets Trend (2008–2025)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 300289 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Beijing Leadman Biochemistry Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Beijing Leadman Biochemistry Co Ltd's total assets of CN¥1.76 Billion consist of 62.1% current assets and 38.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	31.9%
Accounts Receivable	CN¥85.87 Million	4.8%
Inventory	CN¥88.72 Million	5.0%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥20.98 Million	1.2%
Goodwill	CN¥73.53 Million	4.1%

Asset Composition Trend (2008–2025)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Beijing Leadman Biochemistry Co Ltd worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Beijing Leadman Biochemistry Co Ltd's current assets represent 62.1% of total assets in 2025, a decrease from 64.2% in 2008.
Cash Position: Cash and equivalents constituted 31.9% of total assets in 2025, up from 24.8% in 2008.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 4.0% in 2008.
Asset Diversification: The largest asset category is inventory at 5.0% of total assets.

Beijing Leadman Biochemistry Co Ltd Competitors by Total Assets

Key competitors of Beijing Leadman Biochemistry Co Ltd based on total assets are shown below.

Company	Country	Total Assets
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$90.55 Million
Medacta Group SA SW:MOVE	Switzerland	CHF860.76 Million
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.52 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
Xiangyu Medical Co. Ltd. A SHG:688626	China	CN¥3.27 Billion
INKON Life Technology Co Ltd SHE:300143	China	CN¥4.17 Billion

Beijing Leadman Biochemistry Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	13.99	15.64	6.32
Quick Ratio	12.88	14.39	5.48
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.03 Billion	CN¥1.04 Billion	CN¥554.43 Million

Beijing Leadman Biochemistry Co Ltd - Advanced Valuation Insights

This section examines the relationship between Beijing Leadman Biochemistry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.06
Latest Market Cap to Assets Ratio	0.26
Asset Growth Rate (YoY)	-2.5%
Total Assets	CN¥1.78 Billion
Market Capitalization	$467.29 Million USD

Valuation Analysis

Below Book Valuation: The market values Beijing Leadman Biochemistry Co Ltd's assets below their book value (0.26x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Beijing Leadman Biochemistry Co Ltd's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Beijing Leadman Biochemistry Co Ltd (2008–2025)

The table below shows the annual total assets of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥1.78 Billion ≈ $259.91 Million	-2.54%
2024-12-31	CN¥1.82 Billion ≈ $266.68 Million	-5.98%
2023-12-31	CN¥1.94 Billion ≈ $283.65 Million	-2.94%
2022-12-31	CN¥2.00 Billion ≈ $292.24 Million	-14.96%
2021-12-31	CN¥2.35 Billion ≈ $343.65 Million	+44.20%
2020-12-31	CN¥1.63 Billion ≈ $238.32 Million	-4.99%
2019-12-31	CN¥1.71 Billion ≈ $250.84 Million	-0.87%
2018-12-31	CN¥1.73 Billion ≈ $253.04 Million	-1.41%
2017-12-31	CN¥1.75 Billion ≈ $256.65 Million	+5.48%
2016-12-31	CN¥1.66 Billion ≈ $243.33 Million	+0.25%
2015-12-31	CN¥1.66 Billion ≈ $242.72 Million	+2.63%
2014-12-31	CN¥1.62 Billion ≈ $236.50 Million	+29.92%
2013-12-31	CN¥1.24 Billion ≈ $182.03 Million	+10.07%
2012-12-31	CN¥1.13 Billion ≈ $165.38 Million	+209.09%
2011-12-31	CN¥365.66 Million ≈ $53.51 Million	+41.34%
2010-12-31	CN¥258.71 Million ≈ $37.86 Million	+69.09%
2009-12-31	CN¥153.00 Million ≈ $22.39 Million	+34.32%
2008-12-31	CN¥113.91 Million ≈ $16.67 Million	--

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices

Market Cap

$467.29 Million

CN¥3.19 Billion CNY

Market Cap Rank

#12761 Global

#3779 in China

Share Price

CN¥5.87

Change (1 day)

+0.17%

52-Week Range

CN¥4.99 - CN¥11.33

All Time High

CN¥23.05